|
(P1078) |
Impact of Peroxisome Proliferator-Activated Receptor-gamma on cardiomyogenesis using murine embryonic stem cell-derived embryoid bodies as in vitro model |
| |
|
S. Latz, J. Müller, M. M. Elsaied, H. Sauer, P. C. Schulze, M. Wartenberg, for the study group: KIMI Jena (Jena, Gießen) |
|
(P1079) |
Metabolic and molecular analysis of cardiac cells derived from human-induced pluripotent stem cells exposed to diabetes mellitus conditions at different stages of differentiation |
| |
|
M. M. Elsaied, A. G. Delgado, T. Kretzschmar, B. Greber, M. Gräler, P. C. Schulze, for the study group: KIMI Jena (Jena, Münster) |
|
(P1080) |
A mutation (N588K) in hERG channel increased the channel expression in human-induced pluripotent stem cell-derived cardiomyocytes |
| |
|
X. Li, I. El-Battrawy, H. Lan, Z. Zhao, F. Buljubasic, S. Lang, G. Yuecel, K. Sattler, W.-H. Zimmermann, J. Utikal, T. Wieland, U. Ravens, L. Cyganek, M. Borggrefe, X. Zhou, I. Akin (Mannheim, Göttingen, Freiburg im Breisgau) |
|
(P1081) |
Altered Ca Handling in Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes from Arrhythmogenic Right Ventricular Cardiomyopathy Patients with a Plakophilin2 Mutation |
| |
|
M. Giglberger, L. Albersdörfer, T. Stauber, G. Pietrzyk, M. Fischer, A. Bäßler, L. S. Maier, S. Wagner, K. Hammer (Regensburg) |
|
(P1082) |
Human iPSC-derived cardiomyocytes prevent endothelial cell death via exosome release under ischemic conditions |
| |
|
F. Yergoz, H. Renikunta, A. Kratzer, H. Giral, N. Kränkel, G. Hasenfuß, K. Streckfuß-Bömeke, U. Landmesser, P. Jakob (Berlin, Göttingen) |
|
(P1083) |
Production of human engineered heart tissue from induced pluripotent stem cells under cGMP-grade conditions for cardiac repair |
| |
|
M. Reinsch, F. Weinberger, L. Castro, B. Geertz, A. Hansen, T. Eschenhagen (Hamburg) |